Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00232791 | The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions. | PHASE2 | COMPLETED | 102 | — | — | Jan 1, 2004 | Mar 1, 2005 | Aug 6, 2008 | 1 | United Kingdom |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | CYPHER SELECT™ Sirolimus-eluting Coronary Stent |
| 2 | ACTIVE_COMPARATOR | CYPHER™ Sirolimus-eluting Coronary Stent |
| Name | Type | Description |
|---|---|---|
| Cypher Select | DEVICE | CYPHER SELECT™ Sirolimus-eluting Coronary Stent |
| Cypher | DEVICE | CYPHER™ Sirolimus-eluting Coronary Stent |
Inclusion Criteria: 1. Diagnosis of angina pectoris as defined by Canadian Cardiovascular Society Classification (CCS I, II, III, IV) OR unstable angina pectoris (Braunwald Classification B\&C, I-II-III) OR patients with documented silent ischemia; 2. Single treatment of de novo lesion in a coronar...